Neko Health
Category: AI in Healthcare
Neko Health offers AI-powered full-body scans for preventive healthcare, detecting potential health issues early. Neko Health was founded in 2018. The company is led by Hjalmar Nilsonne. Based in Stockholm, Sweden, with clinics in Sweden, the UK and New York City, United States. Team size: 500+. Total funding raised: $325 million. Latest round: Series C. Key investors include Lightspeed Venture Partners, General Catalyst, O.G. Venture Partners, Rosello, Lakestar, Atomico, Prima Materia, Liberty City Ventures, Positive Sum, BDT & MSD.
- Founded
- 2018
- Headquarters
- Stockholm, Sweden, with clinics in Sweden, the UK and New York City, United States
- Team size
- 500+
- Total funding
- $325 million
Value proposition
Early detection of health issues through comprehensive scans, providing insights across multiple health dimensions
Products and solutions
Neko Health Scan: a one-hour preventive health assessment covering skin, cardiovascular, blood and metabolic health, now including body composition analysis and wearable data integration through the Neko Health app and Apple Health
Unique value
Neko Health's proprietary scanning technology provides a comprehensive health assessment in a single session, capturing millions of data points.
Target customer
Individuals seeking preventive healthcare services, particularly those at risk for conditions like skin cancer or heart disease
Industries served
Healthcare, specifically preventive care
Technology advantage
The ability to integrate hardware, software, AI, and data to rapidly innovate and deliver value to customers
How they differentiate
Neko Health's comprehensive and efficient scanning technology, combined with its focus on preventive care, sets it apart
Main competitors
Preventive Health Companies, Traditional Healthcare Providers, Health Tech Startups
Key partnerships
New York follow-up referral network includes General Medicine, Columbia University Irving Medical Center, Schweiger Dermatology and Mount Sinai Health System
Major milestones
June 22, 2026: announced body composition analysis and wearable data integration., July 15, 2026: completed $700 million Series C., September 24, 2026: opened first U.S. clinic in New York City's SoHo.
Growth metrics
As of July 15, 2026, more than 100,000 people scanned in Sweden and the UK and over 350,000 people waitlisted or registered. As of September 24, 2026, 75% book and prepay their second scan after their first appointment; 80% book their third after their second.
Market positioning
Positioned as a leader in preventive healthcare through advanced technology
Geographic focus
Sweden, the UK and the United States, following the New York City clinic opening on September 24, 2026
Patents and IP
Not explicitly mentioned in available sources
About Hjalmar Nilsonne
Hjalmar Nilsonne is the CEO and co-founder of Neko Health, a Swedish health-tech company. He co-founded the company in 2018 with Daniel Ek, the founder of Spotify. Neko Health's vision is to create a healthcare system that can help people stay healthy through preventive measures and early detection. The company offers AI-powered full-body scans to detect potential health issues early.
Latest news about Neko Health
More AI in Healthcare companies
Official website: https://www.nekohealth.com